Literature DB >> 28940506

Molecular and clinical spectra of FBXL4 deficiency.

Ayman W El-Hattab1, Hongzheng Dai2, Mohammed Almannai2, Julia Wang3, Eissa A Faqeih4, Ali Al Asmari4, Mohammed A M Saleh4, Mohammed A O Elamin4, Majid Alfadhel5,6, Fowzan S Alkuraya7,8, Mais Hashem7, Mazhor S Aldosary7, Rawan Almass7, Faten B Almutairi7, Maysoon Alsagob7, Mohammed Al-Owain9, Shirin Al-Sharfa9, Zuhair N Al-Hassnan9, Zuhair Rahbeeni9, Mohammed A Al-Muhaizea8,10, Nawal Makhseed11, Gretchen K Foskett12, David A Stevenson12, Natalia Gomez-Ospina12, Chung Lee12, Richard G Boles13, Samantha A Schrier Vergano14, Saskia B Wortmann15,16,17, Wolfgang Sperl15, Thomas Opladen18, Georg F Hoffmann18, Maja Hempel19, Holger Prokisch16,17, Bader Alhaddad16,17, Johannes A Mayr20, Wenyaw Chan21, Namik Kaya7, Lee-Jun C Wong2.   

Abstract

F-box and leucine-rich repeat protein 4 (FBXL4) is a mitochondrial protein whose exact function is not yet known. However, cellular studies have suggested that it plays significant roles in mitochondrial bioenergetics, mitochondrial DNA (mtDNA) maintenance, and mitochondrial dynamics. Biallelic pathogenic variants in FBXL4 are associated with an encephalopathic mtDNA maintenance defect syndrome that is a multisystem disease characterized by lactic acidemia, developmental delay, and hypotonia. Other features are feeding difficulties, growth failure, microcephaly, hyperammonemia, seizures, hypertrophic cardiomyopathy, elevated liver transaminases, recurrent infections, variable distinctive facial features, white matter abnormalities and cerebral atrophy found in neuroimaging, combined deficiencies of multiple electron transport complexes, and mtDNA depletion. Since its initial description in 2013, 36 different pathogenic variants in FBXL4 were reported in 50 affected individuals. In this report, we present 37 additional affected individuals and 11 previously unreported pathogenic variants. We summarize the clinical features of all 87 individuals with FBXL4-related mtDNA maintenance defect, review FBXL4 structure and function, map the 47 pathogenic variants onto the gene structure to assess the variants distribution, and investigate the genotype-phenotype correlation. Finally, we provide future directions to understand the disease mechanism and identify treatment strategies.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  FBXL4; mitochondrial DNA depletion; mitochondrial DNA maintenance; mitochondrial diseases; mtDNA

Mesh:

Substances:

Year:  2017        PMID: 28940506     DOI: 10.1002/humu.23341

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  14 in total

1.  Fulminant Necrotizing Enterocolitis and Multiple Organ Dysfunction in a Toddler with Mitochondrial DNA Depletion Syndrome-13.

Authors:  Nicolas Nardi; François Proulx; Catherine Brunel-Guiton; Luc L Oligny; Nelson Piché; Grant A Mitchell; Jean Sébastien Joyal
Journal:  J Pediatr Intensive Care       Date:  2019-10-10

Review 2.  The Role of Cullin-RING Ligases in Striated Muscle Development, Function, and Disease.

Authors:  Jordan Blondelle; Andrea Biju; Stephan Lange
Journal:  Int J Mol Sci       Date:  2020-10-26       Impact factor: 5.923

3.  A Mild Phenotype of Mitochondrial DNA Depletion Syndrome Type 13 with a Novel FBXL4 Variant.

Authors:  Ummuhan Oncul; Engin Kose; Fatma Tuba Eminoglu
Journal:  Mol Syndromol       Date:  2021-07-19

Review 4.  The Molecular Genetic Interaction Between Circadian Rhythms and Susceptibility to Seizures and Epilepsy.

Authors:  Christopher J Re; Alexander I Batterman; Jason R Gerstner; Russell J Buono; Thomas N Ferraro
Journal:  Front Neurol       Date:  2020-06-23       Impact factor: 4.003

5.  Metabolite Genome-Wide Association Study (mGWAS) and Gene-Metabolite Interaction Network Analysis Reveal Potential Biomarkers for Feed Efficiency in Pigs.

Authors:  Xiao Wang; Haja N Kadarmideen
Journal:  Metabolites       Date:  2020-05-15

6.  FBXL4-Related Mitochondrial DNA Depletion Syndrome 13 (MTDPS13): A Case Report With a Comprehensive Mutation Review.

Authors:  Rami A Ballout; Chadi Al Alam; Penelope E Bonnen; Martina Huemer; Ayman W El-Hattab; Rolla Shbarou
Journal:  Front Genet       Date:  2019-02-05       Impact factor: 4.599

7.  De Novo Missense Variants in FBXW11 Cause Diverse Developmental Phenotypes Including Brain, Eye, and Digit Anomalies.

Authors:  Richard J Holt; Rodrigo M Young; Berta Crespo; Fabiola Ceroni; Cynthia J Curry; Emanuele Bellacchio; Dorine A Bax; Andrea Ciolfi; Marleen Simon; Christina R Fagerberg; Ellen van Binsbergen; Alessandro De Luca; Luigi Memo; William B Dobyns; Alaa Afif Mohammed; Samuel J H Clokie; Celia Zazo Seco; Yong-Hui Jiang; Kristina P Sørensen; Helle Andersen; Jennifer Sullivan; Zöe Powis; Anna Chassevent; Constance Smith-Hicks; Slavé Petrovski; Thalia Antoniadi; Vandana Shashi; Bruce D Gelb; Stephen W Wilson; Dianne Gerrelli; Marco Tartaglia; Nicolas Chassaing; Patrick Calvas; Nicola K Ragge
Journal:  Am J Hum Genet       Date:  2019-08-08       Impact factor: 11.025

8.  Identification of potential crucial genes in monocytes for atherosclerosis using bioinformatics analysis.

Authors:  Yuan-Meng Zhang; Ling-Bing Meng; Si-Jun Yu; Dong-Xing Ma
Journal:  J Int Med Res       Date:  2020-04       Impact factor: 1.671

9.  FBXL4 deficiency increases mitochondrial removal by autophagy.

Authors:  David Alsina; Oleksandr Lytovchenko; Aleksandra Schab; Ilian Atanassov; Florian A Schober; Min Jiang; Camilla Koolmeister; Anna Wedell; Robert W Taylor; Anna Wredenberg; Nils-Göran Larsson
Journal:  EMBO Mol Med       Date:  2020-06-11       Impact factor: 12.137

10.  Molecular Characterization of New FBXL4 Mutations in Patients With mtDNA Depletion Syndrome.

Authors:  Sonia Emperador; Nuria Garrido-Pérez; Javier Amezcua-Gil; Paula Gaudó; Julio Alberto Andrés-Sanz; Delia Yubero; Ana Fernández-Marmiesse; Maria M O'Callaghan; Juan D Ortigoza-Escobar; Marti Iriondo; Eduardo Ruiz-Pesini; Angels García-Cazorla; Mercedes Gil-Campos; Rafael Artuch; Julio Montoya; María Pilar Bayona-Bafaluy
Journal:  Front Genet       Date:  2020-01-08       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.